HIV/AIDS

To inform future directions for PEPFAR and other U.S. global health programs, this policy brief reviews the graduation policies of several institutions to identify options for consideration.

This analysis examines what the Ending the HIV Epidemic (EHE) initiative has done to date and what its future might look like under the second Trump administration.

This brief identifies time-bound PEPFAR authorities and also provides a detailed side-by-side comparison of PEPFAR’s authorizing legislation over time.

This tracker provides up-to-date data on federal Ending the HIV Epidemic (EHE) funding, including an overview of funding mechanisms by year, agency, grant mechanism, and jurisdiction. It will be updated over time.

This policy watch examines the impact of federal staff cuts and HHS restructuring on the nation’s HIV response.

This brief provides 5 key facts about the role Medicaid plays in delivering care to and financing care for people with HIV.

As the Trump administration works to dissolve the U.S. Agency for International Development (USAID), a new KFF poll finds that two-thirds (67%) of the public believe these actions will increase illness and death in low-income countries, and a similar majority (62%) believe it will result in more humanitarian crises around…

This poll finds most of the public believe the cutbacks at USAID will lead to increases in illness and death in low-income countries. Nearly half say it will reduce the U.S. budget. Most of the public also overestimates the share of the federal budget that is spent on foreign aid, and when informed it is about 1% of the federal budget, the share who want to reduce spending drops.

PEPFAR, the U.S. global HIV/AIDS program, is – for the first time in its two-decade history – facing significant challenges that could impede its ability to fulfill its mission. This policy brief provides an overview of recent events and ongoing challenges facing the program.